Read more: Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Read more: Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Here is the original post: TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update
Continued here: Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
View original post here: Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual...
Read this article: Ocuphire Pharma to Present in the BIO CEO & Investor Conference
Read this article: Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
Original post: Curia Appoints Steve Lavezoli as Vice President, Biologics
Read more: Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
See the rest here: Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany
Recent Comments